Houzen, H.; Kano, T.; Horiuchi, K.; Wakita, M.; Nagai, A.; Yabe, I.
Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan. Pharmaceuticals 2021, 14, 705.
https://doi.org/10.3390/ph14080705
AMA Style
Houzen H, Kano T, Horiuchi K, Wakita M, Nagai A, Yabe I.
Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan. Pharmaceuticals. 2021; 14(8):705.
https://doi.org/10.3390/ph14080705
Chicago/Turabian Style
Houzen, Hideki, Takahiro Kano, Kazuhiro Horiuchi, Masahiro Wakita, Azusa Nagai, and Ichiro Yabe.
2021. "Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan" Pharmaceuticals 14, no. 8: 705.
https://doi.org/10.3390/ph14080705
APA Style
Houzen, H., Kano, T., Horiuchi, K., Wakita, M., Nagai, A., & Yabe, I.
(2021). Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan. Pharmaceuticals, 14(8), 705.
https://doi.org/10.3390/ph14080705
